Ocuflur Eye Drop contains Flurbiprofen 0.03% w/v, a nonsteroidal anti-inflammatory drug (NSAID) indicated for ophthalmic use. It is primarily utilized to reduce inflammation and pain associated with ocular surgery, such as cataract extraction and intraocular lens implantation. Flurbiprofen acts by inhibiting cyclooxygenase enzymes, thereby decreasing the synthesis of prostaglandins, which are mediators of inflammation and pain. Ocuflur Eye Drop is also employed to prevent miosis during intraocular surgery, maintaining pupil dilation to facilitate surgical procedures. The formulation is intended for topical administration to the eye, ensuring localized therapeutic effects with minimal systemic absorption. It is contraindicated in patients with hypersensitivity to Flurbiprofen or other NSAIDs. Caution is advised in individuals with a history of asthma or allergic reactions to NSAIDs. Adverse effects may include transient burning or stinging upon instillation, ocular irritation, or hypersensitivity reactions. Prolonged use should be avoided to reduce the risk of corneal complications. Ocuflur Eye Drop should be used under the supervision of an ophthalmologist, adhering to prescribed dosage and duration to optimize safety and efficacy. Storage should be at controlled room temperature, protected from light and contamination.